Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer (vol 98, pg 1147, 2008)

被引：1
|
作者：
Suzuki, H.
Toyota, M.
Carraway, H.
Gabrielson, E.
Ohmura, T.
Fujikane, T.
Nishikawa, N.
Sogabe, Y.
Nojima, M.
Sonoda, T.
Mori, M.
Hirata, K.
Imai, K.
Shinomura, Y.
Baylin, S. B.
Tokino, T.
机构：
来源：
BRITISH JOURNAL OF CANCER | 2008年 / 99卷 / 02期
关键词：
D O I：
10.1038/sj.bjc.6604507
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Correction to: British Journal of Cancer (2008) 98, 1147–1156. doi:10.1038/sj.bjc.6604259 Owing to an error on the part of the authors, the third author of this paper, H Carraway, was originally submitted and subsequently published as ‘H Caraway’. The correct spelling is given in the author list above.
引用
收藏
页码：384 / 384
页数：1
相关论文
共 50 条
  • [31] A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer (vol 98, pg 1614, 2008)
    Khan, O. A.
    Ranson, M.
    Michael, M.
    Olver, I.
    Levitt, N. C.
    Mortimer, P.
    Watson, A. J.
    Margison, G. P.
    Midgley, R.
    Middleton, M. R.
    BRITISH JOURNAL OF CANCER, 2009, 101 (03) : 550 - 550
  • [32] Impact of breast surgery on survival in women presenting with metastatic breast cancer (vol 98, pg 1566, 2011)
    Pathy, N. Bhoo
    Verkooijen, H. M.
    Taib, N. A.
    Hartman, M.
    Yip, C. H.
    BRITISH JOURNAL OF SURGERY, 2012, 99 (01) : 148 - 148
  • [33] Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients
    Khushnuma Wahabi
    Ahmad Perwez
    Shabeena Kamarudheen
    Zafar Iqbal Bhat
    Anurag Mehta
    M. Moshahid A. Rizvi
    BMC Cancer, 19
  • [34] Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients
    Wahabi, Khushnuma
    Perwez, Ahmad
    Kamarudheen, Shabeena
    Bhat, Zafar Iqbal
    Mehta, Anurag
    Rizvi, M. Moshahid A.
    BMC CANCER, 2019, 19 (01)
  • [35] Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer
    Ai, Lingbao
    Tao, Qian
    Zhong, Sheng
    Fields, C. Robert
    Kim, Wan-Ju
    Lee, Michael W.
    Cui, Yan
    Brown, Kevin D.
    Robertson, Keith D.
    CARCINOGENESIS, 2006, 27 (07) : 1341 - 1348
  • [36] Weekly paclitaxel in the adjuvant treatment of breast cancer (vol 358, pg 1663, 2008)
    Sparano, J. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (01): : 106 - 106
  • [37] Progestin and breast cancer - The missing pieces of a puzzle (vol 51, pg 782, 2008)
    Giersig, C.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2008, 51 (08) : 946 - 946
  • [38] Article on TRPV6 in breast cancer (vol 7, pg 271, 2008)
    Bolanz, K. A.
    Hediger, M. A.
    Landowski, C. P.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (04) : 1000 - 1000
  • [39] Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer (vol 358, pg 1663, 2008)
    Sparano, J. A.
    Wang, M. L.
    Martino, S.
    Jones, V
    Perez, E. A.
    Saphner, T.
    Wolff, A. C.
    Sledge, G. W., Jr.
    Wood, W. C.
    Davidson, N. E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (16): : 1685 - 1685
  • [40] Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity (vol 47, pg 137, 2008)
    Willems, P.
    Claes, K.
    Baeyens, A.
    Vandersickel, V.
    Werbrouck, J.
    De Ruyck, K.
    Poppe, B.
    Van den Broecke, R.
    Makar, A.
    Marras, E.
    Perletti, G.
    Thierens, H.
    Vral, A.
    GENES CHROMOSOMES & CANCER, 2009, 48 (04): : 381 - 381
12345